BIONTECH SE-ADR (BNTX)

US09075V1026 - ADR

113.74  -9.11 (-7.42%)

After market: 113.74 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
18.977B
3,837.14%
17.311B
-8.78%
3.819B
-77.94%
2.692B
-29.51%
2.615B
-2.86%
2.606B
-0.34%
3.057B
17.31%
3.901B
27.61%
4.807B
23.22%
5.571B
15.89%
7.445B
33.64%
EBITDA
YoY % growth
14.856B
34,648.84%
12.423B
-16.38%
1.091B
-91.21%
-1.126B
-203.15%
-1.108B
1.60%
-1.163B
-5.01%
-399.482M
65.66%
742.16M
285.78%
1.392B
87.56%
2.215B
59.12%
3.158B
42.57%
EBIT
YoY % growth
14.781B
18,125.61%
12.3B
-16.79%
908M
-92.62%
-1.342B
-247.82%
-1.267B
5.60%
-1.417B
-11.88%
-1.145B
19.19%
-229.939M
79.92%
520.07M
326.18%
1.268B
143.81%
2.102B
65.77%
Operating Margin
77.89%71.05%23.78%-49.86%-48.45%-54.39%-37.47%-5.89%10.82%22.76%28.23%
EPS
YoY % growth
39.69
56,600.00%
36.93
-6.95%
3.83
-89.63%
-3.13
-181.62%
-3.45
-10.28%
-3.23
6.28%
-2.39
26.09%
0.42
117.70%
2.14
407.29%
4.35
102.83%
8.09
85.99%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.51
-73.27%
-1.66
-26.66%
-2.16
35.85%
0.61
-24.23%
0.38
-24.49%
Revenue
Q2Q % growth
1.07B
-27.65%
266.92M
42.28%
189.6M
47.32%
1.174B
-5.69%
1.254B
17.20%
EBITDA
Q2Q % growth
-165.923M
-122.13%
N/AN/AN/AN/A
EBIT
Q2Q % growth
7.251M
-98.72%
-451.672M
4.61%
-578.904M
36.25%
59.481M
47.96%
164.11M
2,163.27%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.81
20.90%
-1.592.40150.91%
Q2 2024
Q2Q % growth
-3.36
-325.32%
-2.06-1.30-62.82%
Q1 2024
Q2Q % growth
-1.31
-163.90%
-1.11-0.20-18.28%
Q4 2023
Q2Q % growth
1.90
-79.48%
2.47-0.57-23.04%
Q3 2023
Q2Q % growth
0.67
-90.40%
-0.100.77782.45%
Q2 2023
Q2Q % growth
-0.79
-112.25%
-0.980.1919.23%
Q1 2023
Q2Q % growth
2.05
-85.60%
0.151.901,313.17%
Q4 2022
Q2Q % growth
9.26
-23.97%
8.151.1113.62%
Q3 2022
Q2Q % growth
6.98
-43.48%
4.602.3851.88%
Q2 2022
Q2Q % growth
6.45
-40.11%
7.22-0.77-10.72%
Q1 2022
Q2Q % growth
14.24
224.37%
9.344.9052.42%
Q4 2021
Q2Q % growth
12.18
675.80%
7.594.5960.45%
Q3 2021
Q2Q % growth
12.35
1,503.41%
11.221.1310.04%
Q2 2021
Q2Q % growth
10.77
2,934.21%
7.693.0839.98%
Q1 2021
Q2Q % growth
4.39
1,929.17%
3.151.2439.21%
Q4 2020
Q2Q % growth
1.57
703.85%
-0.161.731,100.27%
Q3 2020
Q2Q % growth
-0.88
-576.92%
-0.38-0.50-133.98%
Q2 2020
Q2Q % growth
-0.38 -0.02-0.36-1,714.66%
Q1 2020
Q2Q % growth
-0.24 -0.23-0.01-2.60%
Q4 2019
Q2Q % growth
-0.26 -0.18-0.08-47.93%
Q3 2019
Q2Q % growth
-0.13 -0.160.0319.66%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.245B
39.04%
599.57M645.23M107.62%
Q2 2024
Q2Q % growth
128.7M
-23.26%
147.96M-19.26M-13.02%
Q1 2024
Q2Q % growth
187.6M
-85.31%
436.05M-248.45M-56.98%
Q4 2023
Q2Q % growth
1.479B
-65.43%
1.864B-385M-20.65%
Q3 2023
Q2Q % growth
895.3M
-74.13%
917.14M-21.84M-2.38%
Q2 2023
Q2Q % growth
167.7M
-94.75%
685.05M-517.35M-75.52%
Q1 2023
Q2Q % growth
1.277B
-79.97%
1.457B-180M-12.35%
Q4 2022
Q2Q % growth
4.278B
-22.67%
4.075B203.3M4.99%
Q3 2022
Q2Q % growth
3.461B
-43.14%
2.111B1.35B63.96%
Q2 2022
Q2Q % growth
3.197B
-39.79%
3.962B-765.5M-19.32%
Q1 2022
Q2Q % growth
6.375B
211.20%
4.422B1.953B44.16%
Q4 2021
Q2Q % growth
5.533B
1,501.77%
3.997B1.536B38.42%
Q3 2021
Q2Q % growth
6.087B
8,918.22%
5.291B796.3M15.05%
Q2 2021
Q2Q % growth
5.309B
12,599.76%
3.317B1.992B60.04%
Q1 2021
Q2Q % growth
2.048B
7,294.95%
1.508B540.4M35.84%
Q4 2020
Q2Q % growth
345.4M
1,005.60%
193.59M151.81M78.42%
Q3 2020
Q2Q % growth
67.5M
125.11%
51.608M15.892M30.79%
Q2 2020
Q2Q % growth
41.8M 98.954M-57.154M-57.76%
Q1 2020
Q2Q % growth
27.7M 27.899M-199K-0.71%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -77.92% 1.59% -27.25%
Revenue0% -39.14% 1.24% -1.43%